Analyst Ratings for Novo Nordisk (NVO)
NVO Rating Summary
NVO Price Target Summary
- Highest: $70.00 (HSBC)
- Lowest: $41.00 (Goldman Sachs)
- Average: $52.99
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$52.99 (+37.3%)
* Over Last 12-Mos
Rating Score: 3 / 10
Percentile Rank: 26%
Avg. $ Target:
$52.99 (+37.3%)
* Over Last 12-Mos
Rating Score: 3 / 10
Percentile Rank: 26%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/2/2026 | Goldman Sachs | James Quigley | Downgrade | Neutral (Buy) |
41.00 (63.00) |
37.62 (38.58) |
2.55% | Details |
| 2/12/2026 | Jefferies | Michael Leuchten | Upgrade | Hold (Underperform) |
43.90 (42.10) |
49.12 (38.58) |
-21.46% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
